Peritonitis due to Comamonas acidovorans in a CAPD patient.
López-Menchero
R
R
Sigüenza
F
F
Caridad
A
A
Alonso
J C
JC
Ferreruela
R M
RM
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D016946:Gram-Negative Aerobic Rods and Cocci; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D012008:Recurrence; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D002939:Ciprofloxacin; D014640:Vancomycin; D002442:Ceftazidime